GNT Logo.png
GNT Pharma Announces Approval of IND Application for the Phase III RODIN Trial of Nelonemdaz for Acute Ischemic Stroke Patients
September 08, 2021 06:00 ET | GNT Pharma Co., Ltd
PIII Study for 496 ischemic stroke patients treated with endovascular thrombectomyFirst multi-target neuroprotectant for the intervention of ischemic brain injurySafety and efficacy verified in two...
RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy
June 23, 2021 09:00 ET | RapidPulse, Inc
MIAMI, June 23, 2021 (GLOBE NEWSWIRE) -- RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15...
Participants needed for brain injury research studies at Kessler Foundation
October 19, 2016 11:04 ET | Kessler Foundation
EAST HANOVER, N.J., Oct. 19, 2016 (GLOBE NEWSWIRE) -- Kessler Foundation is recruiting study participants for multiple research programs aimed at improving cognition, mobility, and long-term outcomes...
Mesoblast's Mesenchymal Precursor Cells Induce Functional Recovery in Ischemic Stroke Model
November 11, 2013 06:00 ET | Mesoblast
NEW YORK and MELBOURNE, Australia, Nov. 11, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB) (USOTC:MBLTY) today announced positive preclinical trial results which...